Liles, D. K., Shah, N. R., Scullin, B., Gordeuk, V. R., Smith, W. R., Kanter, J., … Kutlar, A. (2021). Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol, 195(4), e150–e153. https://doi.org/10.1111/bjh.17739

Liles, Darla K., Nirmish R. Shah, Brigid Scullin, Victor R. Gordeuk, Wally R. Smith, Julie Kanter, Maureen M. Achebe, et al. “Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.” Br J Haematol 195, no. 4 (November 2021): e150–53. https://doi.org/10.1111/bjh.17739.

Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, et al. Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol. 2021 Nov;195(4):e150–3.

Liles, Darla K., et al. “Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study.” Br J Haematol, vol. 195, no. 4, Nov. 2021, pp. e150–53. Pubmed, doi:10.1111/bjh.17739.

Liles DK, Shah NR, Scullin B, Gordeuk VR, Smith WR, Kanter J, Achebe MM, Boccia R, Crary SE, Kraft WK, Archer N, Cataldo V, Hardesty BM, Idowu M, Desai PC, Ikeda A, Puthenveetil G, Hassell KL, Sarnaik S, Kutlar A. Long-term biological effects in sickle cell disease: insights from a post-crizanlizumab study. Br J Haematol. 2021 Nov;195(4):e150–e153.